Regulatory <scp>T</scp> cells, interleukin ( <scp>IL</scp> )‐6, <scp>IL</scp> ‐8, <scp>V</scp> ascular endothelial growth factor ( <scp>VEGF</scp> ), <scp>CXC</scp> L10, <scp>CXC</scp> L11, epidermal growth factor ( <scp>EGF</scp> ) and hepatocyte growth factor ( <scp>HGF</scp> ) as surrogate markers of host immunity in patients with renal cell carcinoma

Abstract

Concomitant evaluation of Treg (CD4⁺/CD25(high+)/FOXP3⁺ and CD4⁺/CD25(high+)/FOXP3⁺/CD45RA⁺) and of six soluble factors (IL-6, IL-8 ,VEGF, CXCL10, CXCL11, EGF, HGF) might be a surrogate marker of host immunity in patients with RCC.